Dr Jocelyn Celestin, MD | |
215 Washington Avenue Ext, Albany, NY 12205-5534 | |
(518) 452-2510 | |
(518) 452-2683 |
Full Name | Dr Jocelyn Celestin |
---|---|
Gender | Male |
Speciality | Allergy/immunology |
Experience | 45 Years |
Location | 215 Washington Avenue Ext, Albany, New York |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1710989249 | NPI | - | NPPES |
01716090 | Medicaid | NY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | 204070-1 (New York) | Primary |
2080P0201X | Pediatrics - Pediatric Allergy/immunology | 204070-1 (New York) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Albany Medical Center Hospital | Albany, NY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Albany Medical College | 1759293111 | 910 |
News Archive
Agilent Technologies Inc. today reported revenues of $1.58 billion for the fourth fiscal quarter ended Oct. 31, 2010, 35 percent above one year ago, or 26 percent excluding the effects of the Varian acquisition and recent divestitures. Fourth-quarter GAAP net income was $232 million, or $0.66 per diluted share. Last year's fourth-quarter GAAP net income was $25 million, or $0.07 per share.
SXC Health Solutions Corp., a leading provider of pharmacy benefits management (PBM) services and Health Care Information Technology (HCIT) solutions to the healthcare benefits management industry, announced today that its board of directors has declared a nominal dividend on the issued and outstanding common shares of the Company to effect a two-for-one stock split.
An analysis of diabetes trials worldwide has found they are not addressing key issues relating to the condition with almost two thirds focusing on drug therapy while only one in ten addresses prevention or behavioural therapies.
The online FDA tracking database iPledge - with which all people taking the acne drug isotretinoin, sold by Roche under the brand name Accutane, must register to receive their prescriptions - has caused problems for about 90% of dermatologists.
› Verified 5 days ago
Entity Name | Albany Medical College |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1629008537 PECOS PAC ID: 1759293111 Enrollment ID: O20031125000386 |
News Archive
Agilent Technologies Inc. today reported revenues of $1.58 billion for the fourth fiscal quarter ended Oct. 31, 2010, 35 percent above one year ago, or 26 percent excluding the effects of the Varian acquisition and recent divestitures. Fourth-quarter GAAP net income was $232 million, or $0.66 per diluted share. Last year's fourth-quarter GAAP net income was $25 million, or $0.07 per share.
SXC Health Solutions Corp., a leading provider of pharmacy benefits management (PBM) services and Health Care Information Technology (HCIT) solutions to the healthcare benefits management industry, announced today that its board of directors has declared a nominal dividend on the issued and outstanding common shares of the Company to effect a two-for-one stock split.
An analysis of diabetes trials worldwide has found they are not addressing key issues relating to the condition with almost two thirds focusing on drug therapy while only one in ten addresses prevention or behavioural therapies.
The online FDA tracking database iPledge - with which all people taking the acne drug isotretinoin, sold by Roche under the brand name Accutane, must register to receive their prescriptions - has caused problems for about 90% of dermatologists.
› Verified 5 days ago
Entity Name | Albany Medical College |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1497921688 PECOS PAC ID: 1759293111 Enrollment ID: O20190320001621 |
News Archive
Agilent Technologies Inc. today reported revenues of $1.58 billion for the fourth fiscal quarter ended Oct. 31, 2010, 35 percent above one year ago, or 26 percent excluding the effects of the Varian acquisition and recent divestitures. Fourth-quarter GAAP net income was $232 million, or $0.66 per diluted share. Last year's fourth-quarter GAAP net income was $25 million, or $0.07 per share.
SXC Health Solutions Corp., a leading provider of pharmacy benefits management (PBM) services and Health Care Information Technology (HCIT) solutions to the healthcare benefits management industry, announced today that its board of directors has declared a nominal dividend on the issued and outstanding common shares of the Company to effect a two-for-one stock split.
An analysis of diabetes trials worldwide has found they are not addressing key issues relating to the condition with almost two thirds focusing on drug therapy while only one in ten addresses prevention or behavioural therapies.
The online FDA tracking database iPledge - with which all people taking the acne drug isotretinoin, sold by Roche under the brand name Accutane, must register to receive their prescriptions - has caused problems for about 90% of dermatologists.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Jocelyn Celestin, MD 176 Washington Avenue Ext, Albany, NY 12203-5300 Ph: (518) 264-2510 | Dr Jocelyn Celestin, MD 215 Washington Avenue Ext, Albany, NY 12205-5534 Ph: (518) 452-2510 |
News Archive
Agilent Technologies Inc. today reported revenues of $1.58 billion for the fourth fiscal quarter ended Oct. 31, 2010, 35 percent above one year ago, or 26 percent excluding the effects of the Varian acquisition and recent divestitures. Fourth-quarter GAAP net income was $232 million, or $0.66 per diluted share. Last year's fourth-quarter GAAP net income was $25 million, or $0.07 per share.
SXC Health Solutions Corp., a leading provider of pharmacy benefits management (PBM) services and Health Care Information Technology (HCIT) solutions to the healthcare benefits management industry, announced today that its board of directors has declared a nominal dividend on the issued and outstanding common shares of the Company to effect a two-for-one stock split.
An analysis of diabetes trials worldwide has found they are not addressing key issues relating to the condition with almost two thirds focusing on drug therapy while only one in ten addresses prevention or behavioural therapies.
The online FDA tracking database iPledge - with which all people taking the acne drug isotretinoin, sold by Roche under the brand name Accutane, must register to receive their prescriptions - has caused problems for about 90% of dermatologists.
› Verified 5 days ago
Nancy Wade, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 8 Southwoods Blvd, Albany, NY 12211 Phone: 518-434-1446 Fax: 518-434-2360 | |
David Shulan, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 8 Southwoods Blvd, Albany, NY 12211 Phone: 518-434-1446 Fax: 518-434-2360 | |
Michael Katlan, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 8 Southwoods Blvd, Albany, NY 12211 Phone: 518-434-1446 Fax: 518-434-2360 | |
Janet Claassen, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 8 Southwoods Blvd, Albany, NY 12211 Phone: 518-434-1446 Fax: 518-434-2360 | |
Dr. Muhammad Asghar Pasha, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 215 Washington Avenue Ext, Albany, NY 12205 Phone: 518-452-2510 Fax: 518-452-2683 | |
James Michael Demasi, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 4 Executive Park Dr, Albany, NY 12203 Phone: 518-437-1890 Fax: 518-489-3295 |